Showing results (681-690 of 692) with videos related to
Sort By:
Pageof 70
Journal of Pediatric Gastroenterology and Nutrition|April 15, 2020
Proceedings of the 2018 Advances In Motility and In NeuroGastroenterology: AIMING for the Future Single Topic SymposiumLusine Ambartsumyan, Julie Khlevner, Samuel Nurko, et al.Neurology|June 20, 2024
External Validation of a Model for Persistent Perfusion Deficit in Patients With Incomplete Reperfusion After Thrombectomy: EXTEND-PROCEEDAdnan Mujanovic, Felix C Ng, Mattia Branca, et al.Lancet (London, England)|November 6, 2021
Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance dataLucy A McNamara, Ryan E Wiegand, Rachel M Burke, et al.Journal of Medicinal Chemistry|March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D Scott, Duane E DeMong, Thomas J Greshock, et al.Vaccine|April 17, 2024
Overview of U.S. COVID-19 vaccine safety surveillance systemsJulianne Gee, Tom T Shimabukuro, John R Su, et al.International Journal of Obesity (2005)|May 3, 2018
Maternal smoking during pregnancy and offspring overweight: is there a dose-response relationship? An individual patient data meta-analysisLucia Albers, Christina Sobotzki, Oliver Kuß, et al.Frontiers in Public Health|December 16, 2020
Protocol for a Case-Control Study to Investigate the Association of Pellagra With Isoniazid Exposure During Tuberculosis Preventive Treatment Scale-Up in MalawiScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.Cancer Cell|April 22, 2023
Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancerClare E Weeden, Velimir Gayevskiy, Claire Marceaux, et al.The Lancet. Global Health|April 15, 2022
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control studyScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]A Arora, H Bhaskarane, G Tansir, et al.Pageof 70